Fed. Circ. Undoes 'Cryptic' PTAB Ruling In Pfizer Vaccine Row
The Patent Trial and Appeal Board was "too cryptic" when it upheld one claim in a patent covering Pfizer's blockbuster Prevnar 13 vaccine that had been challenged by Merck, the Federal...To view the full article, register now.
Already a subscriber? Click here to view full article